- Home
- TRNS vs FDMT Comparison
TRNS vs FDMT Comparison
Compare TRNS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TRNS | FDMT |
|---|---|---|
| Founded | 1964 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 542.9M | 513.6M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TRNS | FDMT |
|---|---|---|
| Price | $72.24 | $8.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $116.00 | $34.13 |
| AVG Volume (30 Days) | 144.1K | ★ 725.8K |
| Earning Date | 05-04-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.37 | N/A |
| Revenue | ★ $278,421,000.00 | $37,000.00 |
| Revenue This Year | $21.75 | $21,227.03 |
| Revenue Next Year | $7.55 | $161.87 |
| P/E Ratio | $191.53 | ★ N/A |
| Revenue Growth | ★ 7.30 | N/A |
| 52 Week Low | $50.23 | $2.24 |
| 52 Week High | $97.08 | $12.34 |
Technical Indicators
Market Signals| Indicator | TRNS | FDMT |
|---|---|---|
| Relative Strength Index (RSI) | 47.18 | 46.76 |
| Support Level | $71.05 | $8.11 |
| Resistance Level | $81.17 | $8.80 |
| Average True Range (ATR) | 3.10 | 0.56 |
| MACD | -1.32 | -0.12 |
| Stochastic Oscillator | 34.69 | 25.33 |
Price Performance
Historical ComparisonAbout TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.